Protalix Biotherapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.7% | -36.1% | -57.1% | -7.0% | -46.3% | -14.5% | -16.1% | -22.9% | +74.5% | +2,633.3% | +152.5% | -25.4% | +94.2% | -34.4% | -20.0% | +52.0% | +44.0% | -30.8% | +23.9% | -15.4% | -12.2% | -15.3% | -25.7% | +49.7% | +8.4% | -24.3% | +51.4% | -13.0% | +12.2% | |
| – | +1.3% | -65.2% | -36.4% | +9.5% | -46.9% | -13.0% | -11.7% | -22.9% | +74.5% | +2,360.2% | +160.0% | -31.3% | +92.2% | -44.5% | -29.9% | +88.3% | +60.1% | -33.1% | +31.1% | -16.3% | -12.8% | -15.4% | -38.7% | +71.6% | +10.7% | -27.2% | +55.8% | -14.1% | +11.0% | |
| – | -28.3% | +135.3% | -68.4% | -4.1% | +134.3% | -11.8% | -77.8% | +214.1% | +74.8% | +1,460.8% | +302.0% | -31.1% | +90.8% | -55.8% | -24.8% | +92.7% | +66.0% | -36.6% | +39.5% | -17.1% | -19.1% | -26.1% | -52.9% | +2.7% | +113.4% | -56.1% | +38.1% | -16.4% | -25.7% | |
| – | -28.3% | +135.3% | +13.9% | +9.4% | -43.1% | -11.8% | -9.4% | -23.0% | +74.8% | +1,460.8% | +302.0% | -31.1% | +90.8% | -55.8% | -24.8% | +92.7% | +66.0% | -36.6% | +39.5% | -17.1% | -19.1% | -26.1% | -52.9% | +116.6% | +1.1% | -43.1% | +100.9% | -21.8% | -13.1% | |
| – | – | – | – | – | – | – | – | – | – | +475.9% | +1.3% | -41.4% | +170.4% | +331.2% | -43.6% | -72.9% | +48.3% | -9.9% | +10.0% | -66.6% | +148.3% | +174.8% | -0.6% | -57.4% | +72.1% | +33.2% | +15.0% | -44.8% | +203.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -76.5% | +1,347.7% | +97.0% | -16.2% | -13.5% | -9.1% | +49.3% | +9.4% | -4.8% | +60.4% | +37.2% | -6.4% | +13.3% | +11.5% | +21.1% | |
| – | – | – | – | – | – | – | – | – | – | – | +87.4% | +51.8% | +112.5% | +20.1% | +4.7% | -10.7% | -15.9% | -17.7% | -13.6% | -10.7% | -11.8% | -16.8% | -17.5% | +97.5% | -4.7% | -2.8% | +12.9% | -7.9% | +25.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.7% | -81.0% | -67.6% | +22.0% | -86.2% | +2.3% | -0.3% | -10.6% | +3.5% | +3,607.7% | +64.6% | +45.2% | +1,180.8% | -8.1% | +2.4% | +5.4% | +70.9% | -4.4% | -35.6% | +6.7% | +12.3% | +10.1% | +1.5% | -17.9% | -16.1% | -16.7% | -23.4% | -40.6% | +12.9% | |
| – | +11.1% | +1,442.1% | -66.5% | +22.0% | -86.2% | +2.3% | -0.3% | -10.6% | +3.5% | +3,009.8% | +65.9% | +46.9% | +289.5% | -12.2% | -1.1% | +37.8% | +3.7% | -1.8% | -57.1% | +489.3% | -65.6% | +11.4% | +58.5% | +115.2% | -61.6% | -2.3% | +40.4% | -43.7% | +3.5% | |
| – | – | – | +257.0% | – | – | – | – | – | – | – | – | – | – | – | – | -46.0% | +887.0% | -86.3% | -39.6% | +873.5% | -89.0% | -100.0% | – | +1,001.7% | -98.0% | -7.4% | +1,963.4% | -93.5% | -7.7% | |
| – | – | – | – | +48.5% | -84.1% | +2.3% | -0.3% | -94.7% | +10,011.6% | +109.4% | +0.8% | +148.6% | +52.4% | +84.1% | +100.4% | -58.1% | -0.2% | -24.8% | -8.1% | +10.4% | +87.7% | -30.7% | +24.6% | +11.2% | -3.3% | -16.1% | -26.3% | +4.9% | +16.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.6% | +6.9% | -67.2% | +95.7% | +3.7% | +6.2% | -99.9% | +54,580.4% | +1.1% | – | – | – | |
| – | – | – | -52.6% | -15.4% | -29.6% | -15.8% | -17.7% | -24.4% | +84.6% | +2,555.6% | +162.3% | -30.4% | -64.2% | -171.3% | – | – | – | – | – | -191.6% | – | – | – | – | – | – | – | +28.7% | +11.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +17.5% | +79.5% | +14.3% | -23.1% | -19.6% | -9.7% | +0.0% | +0.0% | +8.5% | +826.4% | +2,193.1% | +12.9% | +1.4% | +5.2% | +4.6% | +7.3% | +1.7% | +0.6% | +2.2% | +6.8% | +29.3% | +12.2% | +0.8% | +96.4% | +51.4% | +9.8% | +70.0% | -1.7% | -3.1% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.